Skip to main content

and
  1. Article

    Open Access

    Medication use and risk of amyotrophic lateral sclerosis—a systematic review

    Studying whether medications act as potential risk factors for amyotrophic lateral sclerosis (ALS) can contribute to the understanding of disease etiology as well as the identification of novel therapeutic tar...

    Can Cui, Jiangwei Sun, Kyla A. McKay, Caroline Ingre, Fang Fang in BMC Medicine (2022)

  2. Article

    Open Access

    Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study

    To investigate whether cerebrospinal fluid (CSF) markers differ between pediatric-onset multiple sclerosis (PoMS, onset < 18 years) and adult-onset (AoMS), and whether these markers are associated with clinica...

    Kyla A. McKay, Ronny Wickström, Jan Hillert in Scientific Reports (2021)

  3. No Access

    Chapter

    Epidemiology of Multiple Sclerosis and Environmental Risk Factors

    Multiple sclerosis (MS) is a complex, chronic disease of the central nervous system that typically is diagnosed in early adulthood but can affect individuals of all ages, including children. Global estimates s...

    Kyla A. McKay, Helen Tremlett in Neuroimmunology (2021)

  4. Article

    Open Access

    Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study

    Persons who develop multiple sclerosis (MS) at a young age may bear a higher genetic risk load than persons who develop MS later in life; however, the contribution of familial influence to the risk of MS, in r...

    Jie Song, Helga Westerlind, Kyla A. McKay, Catarina Almqvist in Journal of Neurology (2019)